Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eduardo Díaz

Showing results (1-10 of 288) with videos related to

Pageof 29
Sort By:
International Microbiology : the Official Journal of the Spanish Society for Microbiology|October 20, 2004
Bacterial degradation of aromatic pollutants: a paradigm of metabolic versatilityEduardo Díaz
Advances in Experimental Medicine and Biology|December 14, 2006
Vascular endothelial growth factor inhibitors in colon cancerEduardo Díaz-Rubio
Molecular Microbiology|November 30, 2005
Iron-reducing bacteria unravel novel strategies for the anaerobic catabolism of aromatic compoundsManuel Carmona, Eduardo Díaz
Environmental Microbiology|June 30, 2022
Genetic characterization of the cyclohexane carboxylate degradation pathway in the denitrifying bacterium Aromatoleum sp. CIBDavid Sanz, Eduardo Díaz
Anales De La Real Academia Nacional De Medicina|January 24, 2012
[The challenge of cancer survival in adults: therapeutic progress from the perspective of the clinican]Eduardo Díaz-Rubio García
Anales De La Real Academia Nacional De Medicina|December 12, 2007
[Targeted therapy for cancer: anti-tyrosine kinase receptor agents]Eduardo Díaz-Rubio García
Anales De La Real Academia Nacional De Medicina|January 29, 2013
[Circulating tumor cells: a new efficacy marker in the treatment of metastatic colorectal cancer]Eduardo Díaz-Rubio García
Anales De La Real Academia Nacional De Medicina|September 10, 2008
[Translational research in clinical oncology: challenges and opportunities]Eduardo Díaz-Rubio García
Anales De La Real Academia Nacional De Medicina|December 4, 2013
[Personalized medicine in oncology: one drug, one biomarker]Eduardo Díaz-Rubio García
Anales De La Real Academia Nacional De Medicina|May 4, 2010
[Biomarkers and anti-EGFR therapies for KRAS wild-type tumors in metastatic colorectal cancer patients]Eduardo Díaz-Rubio García
Pageof 29

Showing results (1-10 of 288) with videos related to

Sort By:
Pageof 29
International Microbiology : the Official Journal of the Spanish Society for Microbiology|October 20, 2004
Bacterial degradation of aromatic pollutants: a paradigm of metabolic versatilityEduardo Díaz
Advances in Experimental Medicine and Biology|December 14, 2006
Vascular endothelial growth factor inhibitors in colon cancerEduardo Díaz-Rubio
Molecular Microbiology|November 30, 2005
Iron-reducing bacteria unravel novel strategies for the anaerobic catabolism of aromatic compoundsManuel Carmona, Eduardo Díaz
Environmental Microbiology|June 30, 2022
Genetic characterization of the cyclohexane carboxylate degradation pathway in the denitrifying bacterium Aromatoleum sp. CIBDavid Sanz, Eduardo Díaz
Anales De La Real Academia Nacional De Medicina|January 24, 2012
[The challenge of cancer survival in adults: therapeutic progress from the perspective of the clinican]Eduardo Díaz-Rubio García
Anales De La Real Academia Nacional De Medicina|December 12, 2007
[Targeted therapy for cancer: anti-tyrosine kinase receptor agents]Eduardo Díaz-Rubio García
Anales De La Real Academia Nacional De Medicina|January 29, 2013
[Circulating tumor cells: a new efficacy marker in the treatment of metastatic colorectal cancer]Eduardo Díaz-Rubio García
Anales De La Real Academia Nacional De Medicina|September 10, 2008
[Translational research in clinical oncology: challenges and opportunities]Eduardo Díaz-Rubio García
Anales De La Real Academia Nacional De Medicina|December 4, 2013
[Personalized medicine in oncology: one drug, one biomarker]Eduardo Díaz-Rubio García
Anales De La Real Academia Nacional De Medicina|May 4, 2010
[Biomarkers and anti-EGFR therapies for KRAS wild-type tumors in metastatic colorectal cancer patients]Eduardo Díaz-Rubio García
Pageof 29